Get a glimpse into our company and investor data—powered by the PitchBook Platform
Provider of biotechnological services. The company uses data generated from the human microbiome to develop therapies to address the needs of patients with inflammatory skin disease.
This information is reserved for PitchBook Platform users. To explore Xycrobe Therapeutics‘s full profile, request access.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.